| AIDS | Acquired Immunodeficiency Syndrome |
| APOBEC3G | Apolipoprotein B mRNA Editing Enzyme Catalytic polypeptide-like 3G |
| CA | Capsid |
| CHD | Cypa Homology Domain |
| CPSF6 | Cleavage and Polyadenylation Specific Factor 6 |
| CypA | Cyclophillin A |
| eIF-5A | Eukaryotic translation Initiation Factor-5A |
| ESCRT-I | Endosomal Sorting Complex Required for Transport I |
| FDA | Food and Drug Association |
| HAART | Highly Advanced AntiRetroviral Therapy |
| HIV | Human Immunodeficiency Virus |
| IN | Integrase |
| Crm1 | Chromosome Region Maintenance-1 |
| LEDGF | Lens Epithelium Derived Growth Factor |
| LTR | Long Terminal Repeat |
| MX2 | human Myxovirus resistance 2 |
| NPC | Nuclear Pore Complex |
| Nup | Nucleoporin |
| NTR | Nuclear Transport Receptor |
| NLS | Nuclear Localisation Signal |
| NES | Nuclear Export Signal |
| PIC | Pre Initiation Complex |
| PPI | Protein-Protein Interaction |
| pTEFb | positive Transcription Elongation Factor b |
| Rev | regulator of virion expression |
| RT | Reverse Transcriptase |
| SAMHD1 | SAM domain and HD domain-containing protein 1 |
| TNPO3 | transportin 3 |
| Tat | Transactivator of Transmembrane |
| TRIM5α | Tripartite Motif-containing protein 5α- isoform |
| TSG101 | Tumor Susceptibility Gene 101 |
| UNAIDS | joint United Nations program for Acquired Immunodeficiency Syndrome |
| V-H interactome | Viral Host Interactome |
| Vif | Viral Infectivity Factor |
| Vpr | Viral Protein R |
| Vpu | Viral Protein U |